Perrigo Company plc Accelerated Share Repurchases, Final Price Paid Per Share
Perrigo Company plc (PRGO) reported Accelerated Share Repurchases, Final Price Paid Per Share of $48.28 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2024-02-27.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare · last filed 2024-02-27
- Perrigo Company plc accelerated share repurchases, final price paid per share for the quarter ending 2018-09-29 was $73.46, a 2.41% increase year-over-year.
- Perrigo Company plc accelerated share repurchases, final price paid per share for the quarter ending 2018-06-30 was $79.42, a 10.81% increase year-over-year.
- Perrigo Company plc accelerated share repurchases, final price paid per share for the quarter ending 2018-03-31 was $81.92.
- Perrigo Company plc accelerated share repurchases, final price paid per share for the quarter ending 2017-09-30 was $71.73.
- Perrigo Company plc accelerated share repurchases, final price paid per share for fiscal 2020 was $48.28.
- Perrigo Company plc accelerated share repurchases, final price paid per share for fiscal 2018 was $77.93, a 8.66% increase from fiscal 2017.
- Perrigo Company plc accelerated share repurchases, final price paid per share for fiscal 2017 was $71.72.
| Period end | Accelerated Share Repurchases, Final Price Paid Per Share 3 month | Accelerated Share Repurchases, Final Price Paid Per Share 6 month | Accelerated Share Repurchases, Final Price Paid Per Share 9 month | Accelerated Share Repurchases, Final Price Paid Per Share 12 month |
|---|---|---|---|---|
| 2020-12-31 | $48.28 10-K · filed 2024-02-27 | |||
| 2018-12-31 | $77.93 10-K · filed 2021-03-01 | |||
| 2018-09-29 | $73.46 10-Q · filed 2019-11-06 | $77.93 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $79.42 10-Q · filed 2019-08-08 | $80.42 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $81.92 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $71.72 10-K · filed 2020-02-27 | |||
| 2017-09-30 | $71.73 10-Q · filed 2018-11-08 | $71.72 10-Q · filed 2018-11-08 | ||
| 2017-07-01 | $71.67 10-Q · filed 2018-08-09 | $71.67 10-Q · filed 2018-08-09 | ||
| 2015-12-31 | $151.59 10-K · filed 2017-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |